Balyasny Asset Management LLC Mimedx Group, Inc. Transaction History

Balyasny Asset Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$5.7 - $9.14 $498,134 - $798,762	87,392 Added 197.0%	131,754 $1.16 Million
Q3 2023 Nov 14, 2023	BUY	$6.35 - $8.16 $281,698 - $361,993	44,362 New	44,362 $323,000
Q4 2022 Feb 14, 2023	BUY	$2.63 - $3.45 $28,937 - $37,960	11,003 New	11,003 $30,000
Q2 2021 Aug 16, 2021	SELL	$9.02 - $12.72 $236,170 - $333,047	-26,183 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$8.48 - $11.28 $317,804 - $422,740	-37,477 Reduced 58.87%	26,183 $270,000
Q2 2018 Aug 14, 2018	SELL	$5.39 - $8.96 $365,388 - $607,398	-67,790 Reduced 51.57%	63,660 $407,000
Q1 2018 May 15, 2018	SELL	$6.69 - $17.96 $11 Million - $29.6 Million	-1,648,550 Reduced 92.62%	131,450 $916,000
Q4 2017 Feb 14, 2018	BUY	$10.87 - $13.9 $19.3 Million - $24.7 Million	1,780,000	1,780,000 $22.4 Million

214

97.9M

65.3K

Ticker MDXG
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 113,609,000
Market Cap $1.03B
Description
MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary pr...

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Balyasny Asset Management LLC with notifications on news.